The clinical and pathological features of the 68 ABC-DLBCL patients are listed in Table 1 according to the presence (20 patients, 29.4%) or absence (48 patients, 70.6%) of the A20 mutation. This evidence concerns the gene TNFAIP3 and diffuse large B-cell lymphoma.